Società Teva Pharmaceutical Industries Limited London S.E.

0LER

US8816242098

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Coordinate società

Società del gruppo

Settore

Vendite per regione

Rating per Teva Pharmaceutical Industries Limited

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Mercato chiuso - London S.E. Altri mercati azionari 17:30:00 17/05/2024			Variaz. 5gg	Var. 1 gen.
16,2 ^USD	-4,42%		-0,64%	+55,25%

17/05	L'insider di Teva Pharmaceutical Industries ha venduto azioni per un valore di 470.794 dollari, secondo un recente deposito SEC	MT
15/05	L'insider di Teva Pharmaceutical Industries ha venduto azioni per un valore di 254.807 dollari, secondo un recente deposito SEC	MT

Teva Pharmaceutical Industries Ltd è un'azienda farmaceutica con sede in Israele. L'azienda opera attraverso tre segmenti: Nord America, Europa e Mercati internazionali. Ogni segmento aziendale gestisce l'intero portafoglio di prodotti nella propria regione, compresi i prodotti generici, quelli speciali e quelli da banco (OTC). Oltre a questi tre segmenti, la Società svolge altre attività, principalmente la vendita di ingredienti farmaceutici attivi (API) a terzi, alcuni servizi di produzione a contratto e una piattaforma di out-licensing che offre un portafoglio di prodotti ad altre aziende farmaceutiche attraverso la sua affiliata Medis.

Numero di dipendenti: 35 737

USD in Milioni	2022	Peso	2023	Peso	Delta
Generics, Innovative Medicines and Over-the-counter Products 100,0 %	14 925	100,0 %	15 846	100,0 %	+6,17%

USD in Milioni	2022	Peso	2023	Peso	Delta
North America 51,3 %	7 452	49,9 %	8 124	51,3 %	+9,02%
Europe 30,5 %	4 525	30,3 %	4 837	30,5 %	+6,90%
International 12,4 %	1 903	12,8 %	1 958	12,4 %	+2,89%
Global 5,8 %	1 045	7,0 %	926	5,8 %	-11,39%

Dirigenti	Titolo	Età	Da
Richard Francis CEO	Chief Executive Officer	55	01/01/23
Eli Kalif DFI	Director of Finance/CFO	51	22/12/19
Eric Hughes CTO	Chief Tech/Sci/R&D Officer	-	01/08/22
Eric Drapé COO	Chief Operating Officer	62	01/01/13
Kathleen Veit CMP	Compliance Officer	-	01/01/10
Amir Elstein BRD	Director/Board Member	67	01/01/95
Yael Ashman IRO	Public Communications Contact	-	01/09/09
Ran Meir IRC	Investor Relations Contact	-	-
Amir Weiss AUD	Comptroller/Controller/Auditor	47	01/06/12
Dov Bergwerk SEC	Corporate Secretary	-	-

Amministratori	Titolo	Età	Da
Gerald Lieberman BRD	Director/Board Member	77	01/09/15
Janet Vergis BRD	Director/Board Member	59	09/06/20
Sol Barer CHM	Chairman	76	01/01/15
Roberto Mignone BRD	Director/Board Member	52	14/07/17
Amir Elstein BRD	Director/Board Member	67	01/01/95
Rosemary Crane BRD	Director/Board Member	64	01/09/15
Richard Francis CEO	Chief Executive Officer	55	01/01/23
Perry Nisen BRD	Director/Board Member	68	14/07/17
Tal Zaks BRD	Director/Board Member	58	01/10/21
Ronit Satchi-Fainaro BRD	Director/Board Member	52	01/06/18

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	1 238 640 597	1 132 639 575 ( 91,44 %)	106 000 000 ( 8,558 %)	91,44 %

Nome	Azioni	%	Valorizzazione
KSM Mutual Funds Ltd. 0,9880 %	11 075 574	0,9880 %	156 M $
Migdal Mutual Funds Ltd. 0,4533 %	5 081 612	0,4533 %	72 M $
THE PHOENIX HOLDINGS LTD. 0,2394 %	2 683 173	0,2394 %	38 M $
Amir Elstein 0,1849 %	2 073 223	0,1849 %	29 M $
Excellence Nessuah Mutual Funds Management Ltd. 0,1470 %	1 647 323	0,1470 %	23 M $
I. G. Investment Management Ltd. 0,0454 %	508 436	0,0454 %	7 M $
IBI Mutual Funds Management (1978) Ltd. 0,0404 %	452 957	0,0404 %	6 M $
Eurizon Capital SGR SpA 0,0393 %	440 794	0,0393 %	6 M $
Phoenix Provident Fund Ltd. 0,0383 %	429 562	0,0383 %	6 M $
Sol Barer 0,0331 %	371 516	0,0331 %	5 M $

Nome	Azioni	%	Valorizzazione
Phoenix Investments House Ltd. 4,552 %	51 032 262	4,552 %	676 M $
Ion Asset Management Ltd. 3,441 %	38 578 487	3,441 %	511 M $
BlackRock Advisors LLC 3,261 %	36 558 073	3,261 %	484 M $
THE PHOENIX HOLDINGS LTD. 3,085 %	34 581 787	3,085 %	458 M $
MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD. 2,664 %	29 857 800	2,664 %	396 M $
CLAL INSURANCE ENTERPRISES HOLDINGS LTD. 2,569 %	28 794 366	2,569 %	382 M $
MENORA MIVTACHIM HOLDINGS LTD 2,509 %	28 128 744	2,509 %	373 M $
Slate Path Capital LP 2,399 %	26 896 184	2,399 %	356 M $
Lingotto Investment Management LLP 2,357 %	26 424 535	2,357 %	350 M $
Fidelity Management & Research Co. LLC 1,895 %	21 248 407	1,895 %	282 M $

Teva Pharmaceutical Industries Ltd.

124 Dvora HaNevi'a Street

6944020, Tel Aviv

+972 3 914 8213

http://www.tevapharm.com

Indirizzo Teva Pharmaceutical Industries Limited(0LER)

Nome	Categoria e settore
Teva Czech Industries sro Teva Czech Industries sro Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Teva Czech Industries sro develops drugs for pharmaceutical preparation. The company is based in Opava, Czechia. Jiri Urbanec has been the CEO of the Czech company since 2006.	Pharmaceuticals: Major
Teva Finance Services BV Teva Finance Services BV Finance/Rental/LeasingFinance Part of Teva Pharmaceutical Industries Ltd., Teva Finance Services BV is a Dutch company that provides finance services. The company is located in the Netherlands.	Finance/Rental/Leasing
Actavis Pharma Development Centre Pvt Ltd. Actavis Pharma Development Centre Pvt Ltd. Pharmaceuticals: GenericHealth Technology Founded in 2006, Actavis Pharma Development Centre Pvt Ltd. is a subsidiary of AbbVie, Inc. that develops, manufactures, and sells generic pharmaceutical products. The company is based in Mumbai, India.	Pharmaceuticals: Generic
Watson Pharma Pvt Ltd. Watson Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Watson Pharma Pvt Ltd. is a pharmaceutical company founded in 2005. The company is based in Mumbai, India. The Indian company manufactures and supplies pharmaceutical products.	Pharmaceuticals: Major
Tevapharm India Pvt Ltd. Tevapharm India Pvt Ltd. Pharmaceuticals: GenericHealth Technology Tevapharm India Pvt Ltd. was founded in 2000 and develops and produces generic and other pharmaceutical medicines. The private company is based in Mumbai, India.	Pharmaceuticals: Generic
Teva Pharmaceutical Industries Teva Pharmaceutical Industries Pharmaceuticals: GenericHealth Technology Part of Teva Pharmaceutical Industries Ltd., the Indian company manufactures and wholesales pharmaceutical products. The company is located in India.	Pharmaceuticals: Generic
Actavis Pharma Pvt Ltd. Actavis Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Actavis Pharma Pvt Ltd. is a pharmaceutical company founded in 2004. The company manufactures pharmaceutical products and is based in Mumbai, India.	Pharmaceuticals: Major
Teva Pharmaceutical & Chemical Industries India Pvt Ltd. Teva Pharmaceutical & Chemical Industries India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2003, Teva Pharmaceutical & Chemical Industries India Pvt Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in New Delhi, India and is a subsidiary of Teva Pharmaceutical Industries Ltd.	Pharmaceuticals: Major
Teva Pharmaceutical Finance Co. BV	Finance/Rental/Leasing
Teva Pharmaceutical Finance IV BV	Finance/Rental/Leasing
Teva Finance Services II BV Teva Finance Services II BV Finance/Rental/LeasingFinance Part of Teva Pharmaceutical Industries Ltd., Teva Finance Services II BV is a Dutch company that provides finance services. The company is located in the Netherlands.	Finance/Rental/Leasing
Teva Pharmaceutical Finance Netherlands II BV	Finance/Rental/Leasing
Teva Pharmaceutical Finance Netherlands IV BV	Finance/Rental/Leasing
Teva Pharmaceutical Finance Netherlands III BV	Finance/Rental/Leasing
Actavis Holding Asia BV Actavis Holding Asia BV Financial ConglomeratesFinance Part of AbbVie, Inc., Actavis Holding Asia BV operates as a holding Dutch company. The company is based in Haarlem, Netherlands.	Financial Conglomerates
Teva Pharmaceuticals USA, Inc. Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.	Pharmaceuticals: Major

Rating Trading

Rating Investimento

ESG Refinitiv

Altri rating

Vendita

Buy

Raccomandazione media

Accumulate

Numero di analisti

Ultimo prezzo di chiusura

16,29 USD

Prezzo obiettivo medio

17,34 USD

Differenza / Target Medio

+6,42%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
ELI LILLY AND COMPANY	+32,09%	693 Mrd
NOVO NORDISK A/S	+29,39%	584 Mrd
JOHNSON & JOHNSON	-1,34%	372 Mrd
MERCK & CO., INC.	+20,34%	332 Mrd
ABBVIE INC.	+7,39%	294 Mrd
ASTRAZENECA PLC	+14,25%	239 Mrd
ROCHE HOLDING AG	-3,03%	211 Mrd
NOVARTIS AG	+10,02%	210 Mrd
AMGEN INC.	+8,49%	168 Mrd

Prodotti farmaceutici - Altri